A survey of young women's perceptions of the influence of the Levonorgestrel-Intrauterine System or copper-intrauterine device on sexual desire

被引:6
作者
Malmborg, Agota
Brynhildsen, Jan
Hammar, Mats
机构
[1] Linkoping Univ, Univ Hosp, Dept Obstet & Gynaecol, SE-58185 Linkoping, Sweden
[2] Linkoping Univ, Univ Hosp, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden
关键词
Contraception; Intrauterine contraceptives; Lng-IUS; Cu IUD; Sexual desire; Sexual function; QUALITY-OF-LIFE; IMPLANTABLE CONTRACEPTIVES; SATISFACTION; CONTINUATION;
D O I
10.1016/j.srhc.2019.06.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: Few studies, with contradictory results, evaluate intrauterine contraceptives (IUC) and sexual function specifically. This study compares perception of sexual desire related to IUC use and aspects of sexual function in women who use the Lng-IUS with those using the Cu-IUD. Study design: A secondary analysis regarding IUC use based on a larger cross-sectional survey of contraceptive use in Sweden, conducted in 2013. In total, 153 IUC users (103 Cu-IUD and 50 Lng-IUS users) answered the questionnaire. The only inclusion criterion was intrauterine contraceptive use. Main outcome measures: Were self-reported sexual desire changes related to contraceptive method. We also analysed aspects of sexual functioning; sexual desire level, sexual activity, orgasm frequency, satisfaction with sex life and satisfaction of desire level. Results: A negative effect on sexual desire due to contraceptive method was reported by 28% of the Lng-IUS users and by 10.1% of the Cu-IUD users (p < 0.05). Results were more marked after adjusting for age, body mass index, depression, parity, switching behaviour, and partnership (OR 5.0; CI: 1.8-13.8). The adjusted odds of reporting low sexual desire level (never or almost never feeling sexual desire) (OR 3.5; CI: 1.1-11.2) as well as low satisfaction with sex life (OR 2.7; CI: 1.2-6.3) was higher in the Lng-IUS group (adjusted for same confounders as above). Conclusions: The women in this study using the Lng-IUS more often report negative sexual desire effects of their contraception as well as lower sexual desire level compared with women using the Cu-IUD.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 38 条
  • [31] Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial
    Jennifer Deese
    Pai Lien Chen
    Xiaoming Gao
    Renee Heffron
    Marcia Hobbs
    Dana Lapple
    Heather Jaspan
    Ashley Miller
    Gonasagrie Nair
    Maricianah Onono
    Thesla Palanee-Phillips
    Krishnaveni Reddy
    Markus J. Steiner
    [J]. AIDS and Behavior, 2023, 27 : 978 - 983
  • [32] Benefits of Self-administered Vaginal Dinoprostone 12 Hours before Levonorgestrel-releasing Intrauterine Device Insertion in Nulliparous Adolescents and Young Women: A Randomized Controlled Trial
    Samy, Ahmed
    Ali, Ahmed Said
    Latif, Dina
    Darweesh, Fatma Faisal
    Ghamry, Nevein Kamal
    Metwally, Ahmed A.
    [J]. JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2020, 33 (04) : 382 - 387
  • [33] Operative Hysteroscopy Versus Levonorgestrel-Releasing Intrauterine System (LNG-IUS) Insertion: A Prospective Observational Study on the Effect of Surgical and Medical Treatments on Sexual Functions in Women With Abnormal Uterine Bleeding
    Evruke, Ipek
    Tas, Inci Sema
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [34] Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa
    Beesham, Ivana
    Bosman, Shannon
    Beksinska, Mags
    Scoville, Caitlin W.
    Smit, Jennifer
    Nanda, Kavita
    [J]. CONTRACEPTION, 2022, 108 : 37 - 43
  • [35] Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial
    Mugo, Nelly R.
    Stalter, Randy M.
    Heffron, Renee
    Rees, Helen
    Scoville, Caitlin W.
    Morrison, Charles
    Kourtis, Athena P.
    Bukusi, Elizabeth
    Beksinka, Mags
    Philip, Neena M.
    Beesham, Ivana
    Deese, Jen
    Edward, Vinodh
    Donnell, Deborah
    Baeten, Jared M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (04) : 586 - 595
  • [36] Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial
    Beksinska, Mags
    Issema, Rodal
    Beesham, Ivana
    Lalbahadur, Tharnija
    Thomas, Katherine
    Morrison, Charles
    Hofmeyr, G. Justus
    Steyn, Petrus S.
    Mugo, Nelly
    Palanee-Phillips, Thesla
    Ahmed, Khatija
    Nair, Gonasagrie
    Baeten, Jared M.
    Smit, Jenni
    [J]. ECLINICALMEDICINE, 2021, 34
  • [37] A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age
    Borgatta, Lynn
    Buhling, Kai J.
    Rybowski, Sarah
    Roth, Katrin
    Rosen, Kimberly
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2016, 21 (05) : 372 - 379
  • [38] Treatment with Medroxyprogesterone Acetate Plus Levonorgestrel-releasing Intrauterine System for Early-stage Endometrial Cancer in Young Women: Single-arm, Prospective Multicenter Study: Korean Gynecologic Oncology Group Study (KGOG2009)
    Kim, Mi Kyoung
    Seong, Seok Ju
    Lee, Taek Sang
    Kim, Jae Weon
    Nam, Byung Ho
    Hong, Sung Ran
    Suh, Kwang Sun
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (12) : 1215 - 1218